Exelon Patch Dosing

Certain factors affect your Exelon Patch dosage, such as other medical conditions. When first starting treatment for Alzheimer's or Parkinson's dementia, dosing starts at one 4.6-mg/24-hour patch applied once daily. If you tolerate the medicine well, your healthcare provider may increase your dose to one 9.5-mg/24-hour patch after four weeks. Exelon Patch dosage guidelines suggest starting over at a lower dosage if the drug is stopped for awhile.

 

Exelon Patch Dosing: An Introduction

The dose of Exelon® Patch (rivastigmine patch) that your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • How you respond to the patch
  • Other medications you may take
  • Other medical conditions you may have.
     
As is always the case, do not adjust your Exelon Patch dose unless your healthcare provider specifically instructs you to do so.
 

Exelon Patch Dosing for Alzheimer's or Parkinson's Dementia

The starting dose of the Exelon Patch for Alzheimer's or Parkinson's dementia is one 4.6-mg/24-hour patch applied once daily. After four weeks (if you tolerate the patch well), your healthcare provider should increase your dose to one 9.5-mg/24-hour patch applied once daily. This is the maximum recommended dose. If you develop bothersome or severe Exelon Patch side effects, your healthcare provider may recommend that you stop using the patch for a short while and then restart at the same or lower dose. If at any time you stop using the Exelon Patch for an extended period, you must start over at the lower dose.
 

Exelon Patch Dosing When Switching From Exelon Capsules or Solution

If you currently take less than 6 mg per day of Exelon capsules or solution, the recommended Exelon Patch dosage is one 4.6-mg/24-hour patch applied once daily. If you take a higher dose, the recommended dose is one 9.5-mg/24-hour patch applied once daily.
 
(Exelon Patch Dosing Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;